|
Re: Nasdaq listing requirements - Another reason for this raise?
|
3
|
Resverlogix Corp.
|
May 30, 2019 08:25AM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 09:49AM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 10:21AM
|
|
Re: Naz listing?
|
5
|
Resverlogix Corp.
|
Apr 20, 2019 08:27AM
|
|
Re: Naz listing?
|
2
|
Resverlogix Corp.
|
Apr 18, 2019 06:29PM
|
|
Re: Naz listing?
|
2
|
Resverlogix Corp.
|
Apr 19, 2019 06:51PM
|
|
Re: need more time, money & partners - FDA response may take until spring - pre market bid/ask..
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 09:10AM
|
|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
4
|
Resverlogix Corp.
|
Sep 04, 2018 12:28AM
|
|
Re: New Apabetalone Publication in Clinical Epigenetics
|
3
|
Resverlogix Corp.
|
Jul 12, 2019 05:58PM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 01:31PM
|
|
Re: New MD&A posted
|
2
|
Resverlogix Corp.
|
Dec 17, 2019 08:09AM
|
|
Re: New MD&A posted
|
3
|
Resverlogix Corp.
|
Dec 17, 2019 08:23AM
|
|
Re: New MD&A posted
|
5
|
Resverlogix Corp.
|
Dec 17, 2019 08:26AM
|
|
Re: New MD&A posted
|
2
|
Resverlogix Corp.
|
Dec 17, 2019 11:08AM
|
|
Re: News out
|
|
Resverlogix Corp.
|
Mar 18, 2019 12:19PM
|
|
Re: News out
|
1
|
Resverlogix Corp.
|
Mar 18, 2019 12:21PM
|
|
Re: News out...offering priced at $4
|
1
|
Resverlogix Corp.
|
May 15, 2019 08:57AM
|
|
Re: News we did it
|
|
Resverlogix Corp.
|
Sep 30, 2019 07:10AM
|
|
Re: Next private placement/licensing agreement
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 12:37PM
|
|
Re: Next private placement/licensing agreement
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 01:36PM
|
